Sienna Biopharmaceuticals, Inc.

Sienna Biopharmaceuticals, Inc.

Sienna Biopharmaceuticals, Inc.

Overview
Date Founded

2010

Headquarters

30699 Russell Ranch Road, Suite 140, Westlake Village, CA, 91362, USA

Type of Company

Public

Employees (Worldwide)

58

Industries

Pharmaceuticals
Medical Support Services
Biotechnology

Company Description

Sienna Biopharmaceuticals, Inc. is a clinical-stage biopharmaceutical company that focuses on the discovery, clinical development, and commercialization of aesthetics and medical dermatology. Its products include Topical by Design platform for patients with inflammatory skin diseases and other dermatologic and aesthetic conditions through SNA-120, SNA-125, and SNA-001. The company was founded by Todd Harris and Frederick C. Beddingfield III on July 27, 2010 and is headquartered in Westlake Village, CA.

Executives & Employees

Secretary & General Counsel

Chief Commercial Officer

Chief Scientific Officer

Head of Development Operations

Head of Corporate Development

Chief of Staff & Head of Regulatory Affairs & Quality

Vice President & Head of Medical Affairs

Vice President, Head of Corporate Development

Vice President, Intellectual Property

Vice President, Operations

Board of Directors

Managing Director at Alta Partners Management Corp.

Former Chief Financial Officer at Allergan Specialty Therapeutics, Inc.

Owner & Chief Executive Officer at Fenton & Associates

Director-Camp Wonder at Children's Skin Disease Foundation

President at Sienna Labs, Inc.

President at International Council of Ophthalmology Foundation

Paths to Sienna Biopharmaceuticals, Inc.
Potential Connections via
Relationship Science
You
Sienna Biopharmaceuticals, Inc.
Recent Transactions
Details Hidden

Sebacia, Inc. purchases Sienna Biopharmaceuticals, Inc. /SNA-001 from Sienna Biopharmaceuticals, Inc.

Details Hidden

Sienna Biopharmaceuticals, Inc. issued USD Common Stock

Details Hidden

Sienna Biopharmaceuticals, Inc. issued USD Common Stock

Transaction Advisors
Underwriter

Advised onSienna Biopharmaceuticals, Inc. issued USD Common Stock

Legal Advisor

Advised onSienna Biopharmaceuticals, Inc. issued USD Common Stock

Escrow Agent

Advised onSienna Biopharmaceuticals, Inc. issued USD Common Stock

Legal Advisor

Advised onSienna Biopharmaceuticals, Inc. issued USD Common Stock

Legal Advisor

Advised onSienna Biopharmaceuticals, Inc. issued USD Common Stock

Knowledge Management Lawyer

Advised onARCH Venture Partners, Two River Group Holdings LLC, Altitude Funds LLC, Sienna Biopharmaceuticals, Inc., VenVest Capital LLP purchase Creabilis Holdings Ltd. from Sofinnova Partners SAS, Kreos Capital Management (UK) Ltd., Neomed Management AS

Advisors & Consultants
Advisor

President at International Council of Ophthalmology Foundation

Advisor

Chief Financial & Accounting Officer at Arcutis Biotherapeutics, Inc.

Legal Advisor

Counsel at Davis Polk & Wardwell LLP

Key Stats and Financials As of 2018
Market Capitalization
$587K
Total Enterprise Value
$28.9M
Earnings Per Share
$-3.59
Net Profit
$-73.5M
EBITDA
$-70M
Total Debt
$30.1M
Total Equity
$26.6M
TEVNet Income
-0.39x
Debt TEV
1.04x
Three Year Compounded Annual Growth Rate Of Revenue
0%
Revenue
$0
Investors
Details Hidden

President at International Council of Ophthalmology Foundation

Details Hidden

President at Sienna Labs, Inc.

Details Hidden

FMR help over 32 million people feel more confident in their most important financial goals, manage employee benefit programs for over 22,000 businesses, and support more than 13,000 financial institutions with innovative investment and technology solutions to grow their businesses.

Suppliers
nanoComposix, Inc. Metal Manufacturing & Products | San Diego, CA

nanoComposix, Inc. manufactures engineered nanoparticles. It provides monodisperse and unagglomerated metal and metal-oxide nanomaterials. The firm’s services include characterization and fabrication. Its characterization services include DLS, Endotixin, ICP-MS, TEM, UV-Vis and Zeta Potential. The firm’s fabrication services include custom synthesis, collaborative R&D, contract manufacturing, GMP fabrication and SBIR & STTR. The company was founded by Steven Oldenburg in 2004 and is headquartered in San Diego, CA.

Competitors
Amorepacific Corp. Personal Products - Seoul, South Korea

Amorepacific Corp. engages in the research, development, and marketing of beauty and health products. It operates through the following divisions: Cosmetics, Personal Care, and Healthcare. The Cosmetics division offers shampoos, body cleansers, and toothpaste under these brands: Hera, Sulwhasoo, Lirikos, Hyosia, Verite, Laneige, IOPE, Mamonde, Haneul, TeenClear, Primera, Lolita Lempicka, Odyssey, Miraepa, Innisfree, Etude, and Espoir. The Personal Care division provides skin care products, makeup products, and fragrances for women and men under the following brands: Mise-en-Scene, Ryoe, Happy Bath, Dantrol, Median, and Songyeum. The Healthcare division includes green tea products under O'Sulloc, VB Program, VB Solution, Natural Beauty Food, and Ketotop brands. The company was founded by Sung-Whan Suh in September 1945 and is headquartered in Seoul, South Korea.

Bausch Health Cos., Inc. Pharmaceuticals - Laval, Canada

Bausch Health Cos., Inc. engages in the development, manufacture, and market of a range of branded, generic and branded generic pharmaceuticals, medical devices and over-the-counter products. It operates through the following segments: The Bausch + Lomb/International, Salix, Ortho Dermatologics and Diversified Products. The Bausch + Lomb/International segment consists of the sale of pharmaceutical products, over-the-counter products, and medical devices products. The Branded Rx segment comprises of pharmaceutical products related to the Salix product portfolio; dermatological product portfolio; branded pharmaceutical products, branded generic pharmaceutical products; over-the-counter products; medical device products; Bausch + Lomb products sold in Canada; and the oncology, dentistry, and health products for women. The Salix Segment consists of sales in the U.S. of GI Products, The Ortho Dermatologics segment consists of sales in the U.S. of Ortho Dermatologics (dermatological) products and global sales of Solta medical aesthetic devices. The Diversified Products segment consists of sales in the U.S. of pharmaceutical products in the areas of neurology and certain other therapeutic classes, in the U.S. of generic products, in the U.S. of dentistry products. The company was founded on March 29, 1994 and is headquartered in Laval, Canada.

GlaxoSmithKline Plc Pharmaceuticals - Brentford, Gbr

GlaxoSmithKline Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the following segments: Pharmaceuticals, Vaccines, Consumer Healthcare, and Corporate Executive Team (CET). The Pharmaceuticals segment focuses on developing medicines in respiratory and infectious diseases, oncology, and immuno-inflammation. The Vaccines segment produces pediatric and adult vaccines to prevent a range of infectious diseases including, hepatitis A and B, diphtheria, tetanus and whooping cough, measles, mumps and rubella, polio, typhoid, influenza, and bacterial meningitis. The Consumer Healthcare segment develops and markets brands in the oral health, pain relief, respiratory, nutrition and gastro intestinal, and skin health categories. The CET segment refers to the management of business activities. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Sienna Biopharmaceuticals, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Sienna Biopharmaceuticals, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Sienna Biopharmaceuticals, Inc..